124 related articles for article (PubMed ID: 12579297)
1. Epigenetic control of E-cadherin (CDH1) by CpG methylation in metastasising laryngeal cancer.
Azarschab P; Stembalska A; Loncar MB; Pfister M; Sasiadek MM; Blin N
Oncol Rep; 2003; 10(2):501-3. PubMed ID: 12579297
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.
Azarschab P; Porschen R; Gregor M; Blin N; Holzmann K
Genes Chromosomes Cancer; 2002 Oct; 35(2):121-6. PubMed ID: 12203775
[TBL] [Abstract][Full Text] [Related]
3. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
4. Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma.
Corn PG; Heath EI; Heitmiller R; Fogt F; Forastiere AA; Herman JG; Wu TT
Clin Cancer Res; 2001 Sep; 7(9):2765-9. PubMed ID: 11555590
[TBL] [Abstract][Full Text] [Related]
5. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
Chang HW; Chow V; Lam KY; Wei WI; Yuen A
Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
Garinis GA; Menounos PG; Spanakis NE; Papadopoulos K; Karavitis G; Parassi I; Christeli E; Patrinos GP; Manolis EN; Peros G
J Pathol; 2002 Dec; 198(4):442-9. PubMed ID: 12434413
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma.
Shieh YS; Shiah SG; Jeng HH; Lee HS; Wu CW; Chang LC
Cancer; 2005 Sep; 104(5):1013-21. PubMed ID: 15999364
[TBL] [Abstract][Full Text] [Related]
10. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
[TBL] [Abstract][Full Text] [Related]
11. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma.
Yeh KT; Shih MC; Lin TH; Chen JC; Chang JY; Kao CF; Lin KL; Chang JG
Anticancer Res; 2002; 22(6C):3971-5. PubMed ID: 12553020
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions.
Chiles MC; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Oct; 16(10):1014-8. PubMed ID: 14559984
[TBL] [Abstract][Full Text] [Related]
13. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
14. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.
Corn PG; Smith BD; Ruckdeschel ES; Douglas D; Baylin SB; Herman JG
Clin Cancer Res; 2000 Nov; 6(11):4243-8. PubMed ID: 11106238
[TBL] [Abstract][Full Text] [Related]
16. Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors.
Lombaerts M; Middeldorp JW; van der Weide E; Philippo K; van Wezel T; Smit VT; Cornelisse CJ; Cleton-Jansen AM
Biochem Biophys Res Commun; 2004 Jun; 319(2):697-704. PubMed ID: 15178462
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
18. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.
Matsumura T; Makino R; Mitamura K
Clin Cancer Res; 2001 Mar; 7(3):594-9. PubMed ID: 11297254
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
